Attend the 7th Annual Allogeneic Cell Therapies Summit
Making Safe, Durable & Effective Universal Cell Therapies a Reality
As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines enter the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable reduced cost of goods and greater access for patients.
As the must-attend meeting for the allogeneic community, the 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.
Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targeting novel cell types and streamlining automated manufacturing processes to support scale-up for larger patient populations.
Keynote Sessions You Won't Want to Miss
Join Cokey Nguyen, President & Chief Executive Officer, at Atara Bio to unleash the promise of cell therapy for cancer and autoimmune disease
Hear Kanya Rajangam, President & Chief Medical Officer at Senti Biosciences, share key clinical readouts in the application of NK cells to haematological malignancies
Discuss how strategic patient selection can maximize treatment outcomes with Enrique Zudaire, Senior Vice President of Translational Sciences at Caribou Biosciences
"This meeting is THE place to discuss opportunities and challenges in allogeneic cell therapies”
SmartImmune, 2025 Speaker
Our World-Class Speaker Faculty Features
Previously Attending Companies Include
"This was the first conference I attended, and I had a great time. I enjoyed how friendly and collaborative everyone was. It was an environment where everyone could come together and discuss and learn together regardless of background”
Sana Biotechnology, 2024 Attendee
Proud to Partner With
"The incredible diversity of technologies and the true innovation delivered by multiple biotechs in the allogeneic field are very promising, and are hopeful to ensure progress in this sector”
NKILT Therapeutics, 2025 Speaker